Innovations in Disease Detection and Genetic Testing

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This Genetic Technology TOE depicts trends across disease detection and genetic testing. Genetic testing has been recommended by the American Society of Clinical Oncology (ASCO) for individuals with suspected cancer risk. The next generation gene sequencing panels help identify other family members at the risk of developing the disease. This study profiles key innovations in the field. The corresponding clinical trial assessment is depicted along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventu

Table of Contents

Innovations in Disease Detection and Genetic TestingInnovation ProfilesNext-Generation Gene Sequencing Panel for Prostate CancerIntegrated Genetic Testing Approach to Support Personalized MedicineGenetic Testing for over 200 Pan-Cardio GenesNovel Disease Detection Kit for Sexually Transmitted InfectionsKey Product Example to Watch For—GSK 2696275 (GSK)Hematopoietic Stem Cell Gene Therapy – Worldwide TrialsIndustry Contacts

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.